Dr. Ayal Aizer of @danafarber.bsky.social spoke with cancer CancerNetwork about Alliance A071801 from #ASTRO26. Fractionated SRS improved surgical bed control after brain metastasis resection. Check it out here: bit.ly/47Rt3OE
Fractionated SRS Should Be Standard of Care After Brain Metastasis Surgery | CancerNetwork
Ayal Aizer, MD, MHS, says Alliance A071801 supports fractionated SRS as standard after resection, with comparable radiation necrosis rates.
bit.ly
"I saw hope in that article." Patient Chris Causey and @danafarber.bsky.social’s Kimmie Ng, MD, MPH, speak with @nbcboston.com about a new study co-led by Dana-Farber showing important differences based on age in #ColorectalCancer tumors. ➡️bit.ly/4yQBEvU
Study aims to find out why colon cancer cases are rising among young people
Chris Causey, a dad in Norwood who was diagnosed with Stage 4 colorectal cancer, said he “saw hope” in the study.
bit.ly
Closing out #BreastCancerAwarenessMonth, Brianne Whitley, CNP, of @danafarber.bsky.social shares strategies for hot flashes, sexual health, survivorship planning, and clinical trial access for men with breast cancer in Oncology Nursing News. #MaleBreastCancer ➡️bit.ly/4e5DmSS
Male Breast Cancer: Managing Endocrine Therapy and Survivorship Care | Oncology Nursing News
Brianne Whitley, CNP, of Dana-Farber, shares strategies for hot flashes, sexual health, survivorship planning, and clinical trial access for men.
bit.ly
Kelly Fischer, MSN, FNP-BC, and Sarah Fischer, NP, of @danafarber.bsky.social detailed their overall impressions and takeaways to Oncology Nursing News after presenting “Antibody-Drug Conjugates in Breast Cancer” at #JADPROLive2026. ➡️bit.ly/4igQh5C
JADPRO Live 2026 Takeaways for Oncology Nurses and APPs | Oncology Nursing News
Dana-Farber nurse practitioners reflect on cross-country networking, resource gaps, and ADC education needs after JADPRO Live 2026.
bit.ly
While receiving intensive treatment for a rare cancer at @danafarber.bsky.social, Elisa Elvira sought an affordable place to stay near her care team. Read in the @bostonglobe.com how organizations are working to expand housing options to keep up with patient demand. bit.ly/4zXXIG8
A baby needed brain surgery in Boston. One of his parents’ biggest hurdles? Finding somewhere to stay. - The Boston Globe
Families coming to Boston seeking life-saving care often stay for weeks or months, hunting to find affordable rooms in one of the country’s most expensive cities.
bit.ly
In the @bostonglobe.com, @danafarber.bsky.social’s Dr. Kimmie Ng explains groundbreaking research mapping 850,000+ cells from 189 tumors creating the largest atlas of its kind - a new roadmap for understanding the rise of young-onset colorectal cancer. ➡️bit.ly/3UnX9pJ
The rise of colon cancer among young people has been a mystery. Boston experts say they now have clues. - The Boston Globe
Boston researchers unveil the largest analysis of colorectal cancer tumor samples to date.
bit.ly
Researchers co-led by @danafarber.bsky.social’s Kimmie Ng, MD, MPH, created the largest single-cell atlas of colorectal cancer ever, identifying age-associated differences that may help research into why #colorectalcancer can be more aggressive in younger adults. ➡️bit.ly/4kmBFEl
Kelly Fischer, MSN, FNP-BC, and Sarah Fischer, NP, of @danafarber.bsky.social shared from #JADPROLive2026 how their team selects patients for ADCs and monitors for lung, nerve, and heart toxicity. #BreastCancerAwareness Read more in Oncology Nursing News: bit.ly/4iatkCr
What Oncology Nurses Need to Know About ADCs in Breast Cancer | Oncology Nursing News
Dana-Farber nurse practitioners outline ADC patient selection, sequencing, ILD surveillance, and patient education from JADPRO Live 2026.
bit.ly
Congratulations to @danafarber.bsky.social’s Judy Garber, MD, recipient of the prestigious 2026 Basser Global Prize in recognition of her pioneering and transformative contributions to the treatment and understanding of BRCA-related cancers. ➡️bit.ly/47GHWn0
Basser Center for BRCA awards 2026 Global Prize to Judy Garber
Judy E. Garber, MD, MPH, of the Dana Farber Cancer Institute is the recipient of the 2026 Basser Global Prize. Awarded by the Basser Center for BRCA at the Abramson Cancer Center of the University of Pennsylvania, the Basser Global Prize recognizes a leading scientist who has advanced BRCA1 and BRCA2-related research. Individuals with mutations in the BRCA1 and BRCA2 genes are at an increased risk of breast, ovarian, pancreatic, and prostate cancers.
bit.ly
In Oncology Nursing News, @danafarber.bsky.social's Brianne Whitley, CNP, details red-flag symptoms, ER-positive biology, and why every man with breast cancer needs a genetic referral. #MaleBreastCancer #BreastCancerAwarenessMonth ➡️bit.ly/4yPdG4r
Dana-Farber researchers are bringing new cancer research and clinical advances to #ESMO26, Oct. 23–27, in Madrid and online. Explore @danafarber.bsky.social faculty’s presentations across cancer types, including new findings in lung, prostate, breast, and kidney cancers. Read more: bit.ly/3WE3j5S
Congratulations to @danafarber.bsky.social’s K. Vish Viswanath, PhD, Kimberly Stegmaier, MD, and Kathleen Burns, MD, PhD, on their election to @nam.edu. ➡️bit.ly/4z1PUD3
New research published in @jem.org from @danafarbernews.bsky.social’s Jun Qi, PhD, and collaborators reveals that AKT inhibitors and EP300 degraders positively combine across cancer cells in a manner dependent on control of protein synthesis. Read more here: bit.ly/4z13y9G
Dana-Farber presents phase 3 lung cancer data in #ESMO26 presidential symposium. Additional key study updates in prostate, breast and kidney cancer, and a special symposium focused on personalized cancer vaccines. @danafarber.bsky.social ➡️bit.ly/4ziMY5n
In @statnews.com: “We’ve been talking about what we'll be able to accomplish with a cancer-focused hospital. But seeing the construction is motivating,” said @danafarber.bsky.social President and CEO Benjamin L. Ebert in celebrating start of work on the hospital set to open in 2031. bit.ly/4dSdutA
Dana-Farber, Beth Israel to begin construction of new $1.68 billion cancer hospital
Dana-Farber Cancer Institute and Beth Israel Lahey Health are starting work on a $1.68 billion cancer hospital in Boston, marking a new phase in their competition with Mass General Brigham.
bit.ly
Yesterday’s groundbreaking for the Lavine Bekenstein Hospital at Dana-Farber marks an important step toward the future of cancer care for patients, families, clinicians, and researchers across our region and beyond. Learn more in the @bostonglobe.com.
Dana-Farber, Beth Israel to begin construction of new $1.68 billion cancer hospital - The Boston Globe
The groundbreaking marks a new phase in the competition with Mass General Brigham. About 2,400 workers will be hired at the facility over the next four years.
bit.ly
In an interview with @noticiastelemundo.com, @danafarber.bsky.social’s @narjustflorezmd.bsky.social shares her perspective following Pope Leo XIV’s recent #lungcancer diagnosis and recovery. ➡️bit.ly/3TBGoaw
Oncóloga cree que "es muy probable" que el papa pase meses tratándose el cáncer | Noticias Telemundo
Video oficial de Noticias Telemundo. Narjust Florez es profesora de Medicina en Harvard y especialista en cánceres torácicos -como el que sufre León XIV- en el Instituto Dana-Farber de Boston. Explica que el hecho de que nunca haya fumado hace posible que su cáncer se deba a una mutación.
bit.ly
Speaking with the @nytimes.com, @danafarber.bsky.social’s Dr. David Barbie shares his insight on the #lungcancer diagnosis and recovery of Pope Leo XIV. ➡️bit.ly/3U3DETo
A New World of Lung Cancer Therapy Awaits Pope Leo
Lung cancer is still a leading cause of cancer death, but that rate is half what it was in the 1990s, partly because newly developed treatments are working.
bit.ly
A study in @jci.org led by @danafarber.bsky.social’s @sethilab.bsky.social on therapy-associated polyposis - which can develop decades after cancer treatment - identified lasting molecular evidence of genetic damage linked to chemotherapy in precancerous colorectal growths. ➡️bit.ly/4hIrB70
This highlights the need for deep molecular and genomic profiling studies" - @danafarber.bsky.social’s Dr. Kimmie Ng discusses research into teens and very young adults diagnosed with colorectal cancer. While rare, the cancer is often diagnosed in late stages. ➡️bit.ly/47Ml31g
In Youngest Patients, CRC Is More Severe and Fatal
Up to age 21, disease tends to be diagnosed late and in advanced stages.
bit.ly
After Pope Leo XIV’s #lungcancer diagnosis, @danafarber.bsky.social’s Dr. David Barbie joined @wbztv.bsky.social to discuss lung adenocarcinoma, recovery, and prognosis. ➡️bit.ly/4B5NKUh
Pope Leo XIV diagnosed with lung cancer
Pope Leo XIV was diagnosed with lung cancer after undergoing surgery. WBZ-TV's Tammy Mutasa reports.
bit.ly
Following Pope Leo XIV’s #lungcancer diagnosis, @danafarber.bsky.social’s Dr. David Barbie spoke with @boston25news.com on lung cancer symptoms and cases in non-smokers. ➡️bit.ly/4dE3YtS
What's next after Pope's cancer surgery
Boston 25 Weather Lindsay Clancy Trial(Opens in new window) Zip Trips(Opens in new window) The Local Life(Opens in new window) Share With Us(Opens in new window)
bit.ly
What to know about lung adenocarcinoma following Pope Leo XIV’s diagnosis. @DanaFarber’s Dr. Jaclyn LoPiccolo spoke with the @nytimes. @DFarberThoracic #lungcancer Read more: www.nytimes.com/2026/10/13/w...
What to Know About Pope Leo’s Lung Cancer Diagnosis
The cancer has a high survival rate if caught in the early stages.
nytimes.com
Following Pope Leo XIV's lung adenocarcinoma diagnosis, @sands_jacob @danafarber spoke with @7News about the diagnosis and importance of #lungcancer screenings. @DFarberThoracic whdh.com/news/dana-fa...
Dana Farber Cancer Institute oncologist speaks about Pope Leo’s cancer diagnosis - Boston News, Weather, Sports | WHDH 7News
BOSTON (WHDH) - Dr. Jacob Sands, MD, from the Dana Farber Cancer Institute, spoke with 7NEWS about Pope Leo’s recent lung cancer diagnosis. Sands is<a class="excerpt-read-more" href="https://whdh.com/news/dana-farber-cancer-institute-oncologist-speaks-about-pope-leos-cancer-diagnosis/">Read More</a>
whdh.com
Congratulations to @danafarber.bsky.social’s @rpozzar.bsky.social who has been inducted into the American Academy of Nursing, one of the most prestigious honors in the nursing profession. Read more: bit.ly/4euzN8J
Congratulations to @danafarber.bsky.social’s Mary-Ellen Taplin, MD, who was honored with the Prostate Cancer Foundation's Women in Science Lifetime Achievement Award. Read more: bit.ly/4zj9nPh
Cancer vaccines featured in @nytimes.com: Following encouraging melanoma and kidney cancer studies led by @danafarber.bsky.social, Dr. Cathy Wu and colleagues are now developing vaccines for patients with glioblastoma and ovarian cancer. ➡️bit.ly/3UhpL40
Cancer Vaccines Are the N.I.H’s Next ‘Big Bet’
New details have emerged about an initiative that starts in December to fast-track the vaccines, similar to the successful push for the Covid-19 vaccine.
bit.ly
Congrats to @danafarber.bsky.social's Joyce Liu, MD, recipient of the NCI’s prestigious Michaele C. Christian Oncology Drug Development Award and Lectureship. Read more: bit.ly/47JKzUO
This week @danafarber.bsky.social welcomed two distinguished leaders: Seth Karp, MD, began his new role as Chair of Surgery, and Gavin P. Dunn, MD, PhD, is now Neurosurgeon-in-Chief at the institute. Read more: bit.ly/4AUc37P
“It’s a beautiful story, from bench to bedside, of understanding a basic pathway in human biology and turning it into a meaningful drug." @danafarber.bsky.social’s @drchoueiri.bsky.social in @acscan.bsky.social discusses the 30-year journey of belzutifan. ➡️ bit.ly/4ziXjO0
How Belzutifan Became a Cancer Drug
The kidney cancer treatment belzutifan took 30 years to go from lab discovery to an available drug. Learn why developing new cancer drugs takes time.
bit.ly